Ebewe, Sanofi Come To Terms Over Eloxatin Patent

Law360, New York (July 9, 2009, 12:00 AM EDT) -- As part of a settlement agreement, Austrian pharmaceutical company Ebewe Pharma Ges.m.b.H. Nfg.KG has agreed to stipulate that it infringed the patents covering Sanofi-Aventis' colon cancer drug Eloxatin.

In a finding of fact, consent judgment and order Thursday, Judge Joel A. Pisano of the U.S. District Court for the District of New Jersey said Ebewe infringed Sanofi's patents when it filed two abbreviated new drug applications with the U.S. Food and Drug Administration.

The judge said that Ebewe had agreed in a settlement agreement to a...
To view the full article, register now.